Evian Gordon
YOU?
Author Swipe
View article: A Deep Learning–Derived Transdiagnostic Signature Indexing Hypoarousal and Impulse Control: Implications for Treatment Prediction in Psychiatric Disorders
A Deep Learning–Derived Transdiagnostic Signature Indexing Hypoarousal and Impulse Control: Implications for Treatment Prediction in Psychiatric Disorders Open
Our results demonstrate the value of the RDoC approach in psychiatry research for the discovery of biomarkers with diagnostic and treatment prediction capacities.
View article: Challenging the Diagnostic Value of Theta/Beta Ratio: Insights From an EEG Subtyping Meta-Analytical Approach in ADHD
Challenging the Diagnostic Value of Theta/Beta Ratio: Insights From an EEG Subtyping Meta-Analytical Approach in ADHD Open
View article: A posterior-alpha ageing network is differentially associated with antidepressant effects of venlafaxine and rTMS
A posterior-alpha ageing network is differentially associated with antidepressant effects of venlafaxine and rTMS Open
Major depressive disorder (MDD) is a highly prevalent psychiatric disorder, but chances for remission largely decrease with each failed treatment attempt. It is therefore desirable to assign a given patient to the most promising individual…
View article: Supplementary Material for: Heartbeat-Evoked Potential in Major Depressive Disorder: A Biomarker for Differential Treatment Prediction between Venlafaxine and rTMS?
Supplementary Material for: Heartbeat-Evoked Potential in Major Depressive Disorder: A Biomarker for Differential Treatment Prediction between Venlafaxine and rTMS? Open
Introduction: Currently, major depressive disorder (MDD) treatment plans are based on trial-and-error, and remission rates remain low. A strategy to replace trial-and-error and increase remission rates could be treatment stra…
View article: Heartbeat-Evoked Potential in Major Depressive Disorder: A Biomarker for Differential Treatment Prediction between Venlafaxine and rTMS?
Heartbeat-Evoked Potential in Major Depressive Disorder: A Biomarker for Differential Treatment Prediction between Venlafaxine and rTMS? Open
Introduction: Currently, major depressive disorder (MDD) treatment plans are based on trial-and-error, and remission rates remain low. A strategy to replace trial-and-error and increase remission rates could be treatment stratification. We…
View article: Independent Replication and Drug-specificity of an Antidepressant Response Polygenic Risk Score
Independent Replication and Drug-specificity of an Antidepressant Response Polygenic Risk Score Open
We here examine associations of a recently published polygenic risk score of antidepressant response (PRS-AR) with antidepressant treatment outcomes (remission and depression score change) in an independent clinical trial. We not only repl…
View article: Brainmarker-I Differentially Predicts Remission to Various Attention-Deficit/Hyperactivity Disorder Treatments: A Discovery, Transfer, and Blinded Validation Study
Brainmarker-I Differentially Predicts Remission to Various Attention-Deficit/Hyperactivity Disorder Treatments: A Discovery, Transfer, and Blinded Validation Study Open
View article: A polygenic-informed approach to a predictive EEG signature empowers stratified antidepressant treatment
A polygenic-informed approach to a predictive EEG signature empowers stratified antidepressant treatment Open
View article: Task independent transfer learning in EEG deep-learning classification tasks: Sex classification and anti-depressant response prediction
Task independent transfer learning in EEG deep-learning classification tasks: Sex classification and anti-depressant response prediction Open
View article: Brainmarker-I: a transdiagnostic EEG biomarker predicting remission to various depression and ADHD treatments
Brainmarker-I: a transdiagnostic EEG biomarker predicting remission to various depression and ADHD treatments Open
View article: Exploring the role of Polygenetic risk scores for MDD treatment outcome in sex and different antidepressants groups
Exploring the role of Polygenetic risk scores for MDD treatment outcome in sex and different antidepressants groups Open
View article: Biomarker-based treatment stratification in ADHD: An out-of-sample validation
Biomarker-based treatment stratification in ADHD: An out-of-sample validation Open
Attention-deficit/hyperactivity disorder (ADHD) is characterized by neurobiological heterogeneity, possibly explaining why not all patients benefit from a given treatment. As a means to select the right treatment (stratification), biomarke…
View article: Antidepressant side effects and their impact on treatment outcome in people with major depressive disorder: an iSPOT-D report
Antidepressant side effects and their impact on treatment outcome in people with major depressive disorder: an iSPOT-D report Open
Side effects to antidepressant medications are common and can impact the prognosis of successful treatment outcome in people with major depressive disorder (MDD). However, few studies have investigated the severity of side effects over the…
View article: A polygenic-informed approach to a predictive EEG signature empowers stratified antidepressant treatment
A polygenic-informed approach to a predictive EEG signature empowers stratified antidepressant treatment Open
The treatment of major depressive disorder (MDD) is hampered by low chances of treatment response in each treatment step, which is partly due to a lack of firmly established outcome-predictive biomarkers. Here, we hypothesize that polygeni…
View article: Can polygenic-informed EEG biomarkers predict differentialantidepressant treatment response? An EEG stratificationmarker for rTMS and sertraline
Can polygenic-informed EEG biomarkers predict differentialantidepressant treatment response? An EEG stratificationmarker for rTMS and sertraline Open
The treatment of major depressive disorder (MDD) is hampered by low chances of treatment response in each treatment step, which is partly due to a lack of firmly established outcome-predictive biomarkers. Here, we hypothesize that polygeni…
View article: The end of skill mix?
The end of skill mix? Open
View article: Profound and reproducible patterns of reduced regional gray matter characterize major depressive disorder
Profound and reproducible patterns of reduced regional gray matter characterize major depressive disorder Open
View article: Journal of Integrative Neuroscience
Journal of Integrative Neuroscience Open
View article: Annual variation in attentional response after Methylphenidate treatment
Annual variation in attentional response after Methylphenidate treatment Open
Prevalence rates of Attention-Deficit/Hyperactivity Disorder (ADHD) differ with geographical areas varying in sunlight intensity. We here studied 1) annual variation in inattention at treatment initiation; 2) annual variation in response t…
View article: Gender-specific structural abnormalities in major depressive disorder revealed by fixel-based analysis
Gender-specific structural abnormalities in major depressive disorder revealed by fixel-based analysis Open
View article: 19th biennial IPEG Meeting
19th biennial IPEG Meeting Open
View article: Book review: Reviewing the review
Book review: Reviewing the review Open
View article: Utility of event-related potentials in predicting antidepressant treatment response: An iSPOT-D report
Utility of event-related potentials in predicting antidepressant treatment response: An iSPOT-D report Open
View article: The overriding objective
The overriding objective Open
View article: Toward an online cognitive and emotional battery to predict treatment remission in depression
Toward an online cognitive and emotional battery to predict treatment remission in depression Open
The test battery identified about 50% of each medication group as being ≥10% more or less likely to remit than by chance, and identified about 38% of individuals who did not remit with ≥80% certainty. Clinicians might choose to avoid this …